Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Levobetalol Ophthalmic Solution in Primary Open-Angle Glaucoma
CTR20171325Phase 3Completed
- Sponsor
- Anhui Cologne Pharmaceutical Research Institute
- Start
- Mar 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levobetaxolol in open-angle glaucoma (OAG), ocular hypertension, sponsored by Anhui Cologne Pharmaceutical Research Institute. Started Mar 2019; status: completed.
02
Drugs
levobetaxolol
03
Conditions
open-angle glaucoma (OAG)ocular hypertension
Beyond the preview
Go deeper on CTR20171325.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20171325.